Development and validation of prognostic models based on 18F-FDG PET radiomics, metabolic parameters, and clinical factors for elderly DLBCL patients

被引:1
作者
Yang, Tianshuo [1 ]
Sun, Zhuxu [1 ]
Shi, Yuye [2 ]
Teng, Yue [3 ]
Cheng, Luyi [1 ]
Zhu, Ronghua [1 ]
Zhang, Huai [1 ]
Wang, Qiuhu [1 ]
Wei, Jing [1 ]
Ding, Chongyang [4 ]
Tao, Weijing [1 ]
机构
[1] Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Nucl Med, Huaian, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Hematol, Huaian, Jiangsu, Peoples R China
[3] Nanjing Drum Tower Hosp, Dept Nucl Med, Nanjing, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Affiliated Hosp 1, Dept Nucl Med, Nanjing, Jiangsu, Peoples R China
关键词
Diffuse large B cell lymphoma; Elderly; F-18-FDG PET/CT; Radiomics; Nomogram; B-CELL LYMPHOMA; NCCN-IPI; INVOLVEMENT; IMPACT;
D O I
10.1007/s00277-024-06071-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study aimed to assess the predictive value of baseline F-18-FDG PET radiomics features, metabolic parameters, and clinical factors for PFS and OS in elderly DLBCL patients. Using LASSO COX regression, we derived Radscore from PET radiomics features. We constructed and externally validated prognostic models, evaluating their performance through various metrics. From 341 training set patients and 83 external validation set patients revealed significant correlations between PET radiomics features and survival outcomes. Multivariate COX analysis identified associations of radiomics features (Radscore), metabolic parameters (TMTV, Dmax), and clinical factors (ECOG PS, hemoglobin level) with PFS and OS. In external validation, the combined model incorporating radiomic features, metabolic parameters, and clinical factors showed superior predictive performance for PFS and OS compared to other models. The combined model had higher C-index values for both PFS and OS, and its td-ROC curves exhibited significantly higher AUCs. Calibration curves demonstrated good consistency, and DCA revealed a higher net benefit for the combined model. In conclusion, the combined model that incorporated F-18-FDG PET radiomics features, metabolic parameters, and clinical factors demonstrated superior prognostic predictive ability, providing a useful tool for personalized treatment decisions in elderly DLBCL patients.
引用
收藏
页码:5583 / 5598
页数:16
相关论文
共 43 条
  • [1] 18F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?
    Albano, Domenico
    Treglia, Giorgio
    Dondi, Francesco
    Calabro, Anna
    Rizzo, Alessio
    Annunziata, Salvatore
    Guerra, Luca
    Morbelli, Silvia
    Tucci, Alessandra
    Bertagna, Francesco
    [J]. CANCERS, 2023, 15 (09)
  • [2] Low skeletal muscle mass and treatment outcomes among adults with haematologic malignancies: A systematic review and meta-analysis
    Anabtawi, Nadia M.
    Pasala, Monica Sai
    Grimshaw, Alyssa A.
    Kharel, Prakash
    Bal, Susan
    Godby, Kelly
    Siwakoti, Ashmita
    Buford, Thomas W.
    Bhatia, Smita
    Costa, Luciano J.
    Williams, Grant R.
    Giri, Smith
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024, 15 (03) : 1084 - 1093
  • [3] Comprehensive Geriatric Assessment (CGA): A Simple Tool for Guiding the Treatment of Older Adults with Diffuse LargeB-CellLymphoma in China
    Bai, Jie-Fei
    Han, Hui-Xiu
    Feng, Ru
    Li, Jiang-Tao
    Wang, Ting
    Zhang, Chun-Li
    Liu, Hui
    [J]. ONCOLOGIST, 2020, 25 (08) : E1202 - E1208
  • [4] Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium
    Barrington, Sally F.
    Zwezerijnen, Ben G. J. C.
    de Vet, Henrica C. W.
    Heymans, Martijn W.
    Mikhaeel, N. George
    Burggraaff, Coreline N.
    Eertink, Jakoba J.
    Pike, Lucy C.
    Hoekstra, Otto S.
    Zijlstra, Jose M.
    Boellaard, Ronald
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (03) : 332 - 337
  • [5] Advances in positron emission tomography and radiomics
    Barrington, Sally F. F.
    [J]. HEMATOLOGICAL ONCOLOGY, 2023, 41 : 11 - 19
  • [6] Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective study
    Buckstein, Rena
    Wells, Richard A.
    Zhu, Nancy
    Leitch, Heather A.
    Nevill, Thomas J.
    Yee, Karen W. L.
    Leber, Brian
    Sabloff, Mitchell
    St Hilaire, Eve
    Kumar, Rajat
    Geddes, Michelle
    Shamy, April
    Storring, John
    Kew, Andrea
    Elemary, Mohamed
    Levitt, Max
    Lenis, Martha
    Mamedov, Alex
    Zhang, Liying
    Rockwood, Ken
    Alibhai, Shabbir M. H.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (01) : 88 - 101
  • [7] Diffuse Large B-Cell Lymphoma: Current Strategies and Future Directions
    Cultrera, Jennifer L.
    Dalia, Samir M.
    [J]. CANCER CONTROL, 2012, 19 (03) : 204 - 213
  • [8] Prognostic parameters on baseline and interim [18F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients
    Czibor, Sandor
    Carr, Robert
    Redondo, Francisca
    Auewarakul, Chirayu U.
    Cerci, Juliano J.
    Paez, Diana
    Fanti, Stefano
    Gyorke, Tamas
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (04) : 291 - 301
  • [9] Challenges and Opportunities in the Management of Diffuse Large B Cell Lymphoma in Older Patients
    Di, Mengyang
    Huntington, Scott F.
    Olszewski, Adam J.
    [J]. ONCOLOGIST, 2021, 26 (02) : 120 - 132
  • [10] Towards a simple objective framework for the investigation and treatment of cancer cachexia: The Glasgow Prognostic Score
    Douglas, Euan
    McMillan, Donald C.
    [J]. CANCER TREATMENT REVIEWS, 2014, 40 (06) : 685 - 691